Article
Engineered CRISPR RNA improves the RNA cleavage efficiency of hfCas13X.
FEBS letters - 1 Oct 2024
Liu Zehui, Zhang Wenxia, Wang Haili, Shangguan Pingping, Pan Tong, Yang Yimu, Zhang Yi, Mao Xi, Liu Yingle, Zhang Qi
Abstract excerpt
As the most compact variant in the Cas13 family, CRISPR-Cas13X holds considerable promise for gene therapy applications. The development of high-fidelity Cas13X (hfCas13X) mutants has enhanced the safety profile for in vivo applications. However, a notable reduction in on-target cleavage efficiency accompanies the diminished collateral cleavage activity in hfCas13X. In this study, we obtained two engineered crRNA...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
